Work

Retatrutide-Induced Intractable Diarrhea

Year: 2026

Type: article

Abstract: Gastrointestinal symptoms accompanying the use of glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide receptor-GLP-1 receptor co-agonists have been extensively catalogued. This case report contains a dramatic presentation of unintended consequences from the use of a novel triple-hormone receptor agonist and points toward the need for increased regulatory measures regarding the marketing of these treatments.

Source: Annals of Internal Medicine Clinical Cases

DOI: 10.7326/aimcc.2025.1218

Author: Opeyemi Komolafe

Institution: Medical University of South Carolina

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W7151243946

FWCI: 9.38

Cites: 5

Cited by: 2

Related to: